Science Explorer Interactive view Map
Company · Malvern · United States

Progenra (United States)

progenra.comROR OpenAlex
Research works
45
▼ 60% vs 2013–17
Citations
2.1k
45.5 per fractional work
Top-10% rate
50.6%
record average 16.5%
Open access
51%
world 28%

Not ranked overall: Progenra (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.49× its world share, 1 worksBiochemistry, Geneti…Pharmacology, Toxicology and Pharmaceutics: 11.45× its world share, 0 worksPharmacology, Toxico…Engineering: 0.32× its world share, 0 worksEngineeringMedicine: 3.40× its world share, 3 worksMedicineEconomics, Econometrics and Finance: 1.89× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.24× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.4×. Every wedge is a field page.

Who are the top researchers at Progenra (United States)?

Ranked on the composite score, Michael R. Mattern, Benjamin Nicholson and Joseph Weinstock lead among researchers whose main affiliation is Progenra (United States).

  1. 1 Michael R. Mattern United States · #197,621 worldwide 203 citations · 27 works
  2. 2 Benjamin Nicholson United States · #356,878 worldwide 118 citations · 17 works
  3. 3 Joseph Weinstock United States · #423,291 worldwide 66 citations · 25 works
  4. 4 Jian Wu United States · #715,421 worldwide 46 citations · 27 works
All ranked researchers at Progenra (United States)

Which keywords describe research at Progenra (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Therapy, Proteasome Inhibitors, Proteasome, Ubiquitin, Tumor Microenvironment, Transcriptional Regulation, BET Bromodomains and PROTACs.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 32 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 32 words, with their numbers
  1. Cancer Therapy22▲ 77×7 topics
  2. Proteasome Inhibitors14▲ 441×2 topics
  3. Proteasome14▲ 755×1 topic
  4. Ubiquitin14▲ 755×1 topic
  5. Tumor Microenvironment5▲ 33×4 topics
  6. Transcriptional Regulation4▲ 38×2 topics
  7. BET Bromodomains4▲ 447×1 topic
  8. Cancer4▲ 6.5×10 topics
  9. PROTACs4▲ 447×1 topic
  10. Gene Expression4▲ 13×3 topics
  11. Apoptosis4▲ 20×5 topics
  12. PET Imaging3▲ 31×2 topics
  13. Fibroblast Activation Protein3▲ 129×1 topic
  14. Immunosuppression3▲ 57×1 topic
  15. Epigenetic Regulation3▲ 29×2 topics
  16. HDAC Inhibitors3▲ 296×1 topic
  17. Histone Deacetylases3▲ 296×1 topic
  18. Mutation2▲ 35×2 topics
  19. Cell Cycle2▲ 79×1 topic
  20. Regulation2▲ 7.7×2 topics
  21. p532▲ 105×1 topic
  22. Immunity2▲ 13×5 topics
  23. Immune System2▲ 11×3 topics
  24. Cell Death2▲ 16×4 topics
  25. Inflammation2▲ 1.37×4 topics
  26. Oxidative Stress1▲ 1.62×4 topics
  27. Glycosylation1▲ 12×2 topics
  28. HIF-11▲ 32×1 topic
  29. Warburg Effect1▲ 32×1 topic
  30. Glycans1▲ 28×1 topic
  31. Mucins1▲ 28×1 topic
  32. Parkinson's Disease1▲ 9.7×2 topics

Which research topics does Progenra (United States) publish most on?

By volume in 2022–2025: Medication Adherence and Compliance, SARS-CoV-2 and COVID-19 Research, Ubiquitin and proteasome pathways and SARS-CoV-2 detection and testing.

Medication Adherence and…1Medication Adherence and Compliance: 1 fractional worksSARS-CoV-2 and COVID-19 Research: 0 fractional worksUbiquitin and proteasome…0Ubiquitin and proteasome pathways: 0 fractional worksSARS-CoV-2 detection and…0SARS-CoV-2 detection and testing: 0 fractional worksInfluenza Virus Research Studies: 0 fractional worksAutophagy in Disease and Therapy: 0 fractional worksParkinson's Disease Mech…0Parkinson's Disease Mechanisms and Treatments: 0 fractional worksGlycosylation and Glycoproteins Research: 0 fractional worksCardiovascular Issues in Pregnancy: 0 fractional worksPharmaceutical industry and healthcare: 0 fractional works
Family PracticeInfectious DiseasesMolecular BiologyEpidemiology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Medication Adherence and Compliance Family Practice 1 works
  2. 2 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  3. 3 Ubiquitin and proteasome pathways Molecular Biology 0 works
  4. 4 SARS-CoV-2 detection and testing Infectious Diseases 0 works
  5. 5 Influenza Virus Research Studies Epidemiology 0 works
  6. 6 Autophagy in Disease and Therapy Epidemiology 0 works
  7. 7 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  8. 8 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  9. 9 Cardiovascular Issues in Pregnancy Cardiology and Cardiovascular Medicine 0 works
  10. 10 Pharmaceutical industry and healthcare Pharmacology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.4%not open48.6%

World: 28% of research is openly available.

with international co-authors15.8%domestic only84.2%

World: 19% is written across borders.

How has Progenra (United States)'s research output changed?

Output in 2018–2022 was 60% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Malvern

All research institutions in Malvern

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.